发明名称 |
Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure |
摘要 |
<p>The present invention relates to a method of monitoring a medication in a subject subjected to said medication, said medication being selected from ACE inhibitors, angiotension receptor blockers and aldosterone antagonists. Also concerned is a method of deciding on the adaptation of a medication selected from ACE inhibitors, angiotension receptor blockers and aldosterone antagonists in a subject.</p> |
申请公布号 |
EP2609427(B1) |
申请公布日期 |
2015.01.21 |
申请号 |
EP20110743231 |
申请日期 |
2011.08.03 |
申请人 |
ROCHE DIAGNOSTICS GMBH;F.HOFFMANN-LA ROCHE AG |
发明人 |
WIENHUES-THELEN, URSULA-HENRIKE;BLOCK, DIRK;HÜDIG, HENDRIK;VOGEL-ZIEBOLZ, SABINE;BÖHM, CHRISTINE |
分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|